SIGA Technologies
SIGA
#7361
Rank
C$0.61 B
Marketcap
C$8.57
Share price
-2.21%
Change (1 day)
1.14%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$38.85 Million

According to SIGA Technologies's latest financial reports the company's total liabilities are C$38.85 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$40.94 M-46.31%
2023-12-31C$76.25 M125.91%
2022-12-31C$33.75 M-34.46%
2021-12-31C$51.5 M101.58%
2020-12-31C$25.55 M-80.59%
2019-12-31C$0.13 B-3.88%
2018-12-31C$0.13 B-76.72%
2017-12-31C$0.58 B-2.39%
2016-12-31C$0.60 B-7.61%
2015-12-31C$0.65 B38.01%
2014-12-31C$0.47 B151.03%
2013-12-31C$0.18 B143.99%
2012-12-31C$77.15 M52.9%
2011-12-31C$50.46 M237.39%
2010-12-31C$14.95 M-24.24%
2009-12-31C$19.74 M124.18%
2008-12-31C$8.8 M64.68%
2007-12-31C$5.34 M-31.91%
2006-12-31C$7.85 M134.73%
2005-12-31C$3.34 M79.57%
2004-12-31C$1.86 M162.01%
2003-12-31C$0.71 M-31.45%
2002-12-31C$1.03 M-2.24%
2001-12-31C$1.06 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Emergent BioSolutions
EBS
C$1.21 B 3,023.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$69.17 M 78.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.84 B 4,652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$1.8 M-95.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$1.15 B 2,866.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.00 B 7,627.58%๐Ÿ‡บ๐Ÿ‡ธ USA